Anti-Dabigatran Etexilate Mesylate Recombinant Antibody
-
产品编号
YR1307
-
别名
科研级 Idarucizumab ( 艾达赛珠单抗 ), Anti-Dabigatran Etexilate Mesylate Recombinant Antibody, Research Grade Idarucizumab
-
规格
- 1mg
- 5mg
产品介绍
| Alias | 科研级 Idarucizumab ( 艾达赛珠单抗 ), Anti-Dabigatran Etexilate Mesylate Recombinant Antibody, Research Grade Idarucizumab |
| Catalog Number | YR1307 |
| Molecular Name | Idarucizumab |
| Host | Mouse |
| Size | 1mg, 5mg |
| Clonity | Monoclonal |
| Purity | >95% as determined by SDS-PAGE |
| Concentration | 1mg/ml |
| Antibody Isotype | Fab |
| Formulation | PBS, pH7.5 |
| Background | Idarucizumab, sold under the brand name Praxbind, is a monoclonal antibody used as a reversal agent for dabigatran. Idarucizumab was developed by Boehringer Ingelheim. One study sponsored by the manufacturer found that idarucizumab effectively reversed anticoagulation caused by dabigatran within minutes. |
| CAS Number | 1362509-93-0 |
| Application | IP, IF, FuncS, FCM, Neut, ELISA, IHC, PK, Activ |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Remarks | This product is for research use only. |
| Shipping Condition | Shipped on ice packs. |
| Target | dabigatran etexilate mesylate[Drug] |
- 联系我们
- 电话：400-621-6806
- 手机：13116038708
- 邮箱：info@kmdbioscience.com
- 地址：天津市武清区国际企业社区A5号楼
-
销售微信
-
官方公众号
-
400-621-6806 -
614353794 -
周一至周五 9:00-18:00 -
-
0
-
